Distributing since 1889 • Employee Owned for Better Service
Your 1st Choice!
Sign In
Quick Search:

Shopping Cart Cart |  My Account |  View Printable Page Print
Ordering
Advanced Search
Fast Order Entry
Express Order Entry
Can't Find Title?
Shopping Cart
Lists
New Receipts
Recall Information
Forthcoming Titles
Latest Price Changes
Downloads
About Us
Home Page
About Matthews
Return Policy
New Account Application
Publisher List
McCoy Medical
Med-Book
Contact Us
Job Opportunities
FAQ
Terms of Use
Product Detail

Biomarkers in Drug Development: A Handbook of Practice, Application, and Strategy
Bleavins, Michael R. PhD
Biomarkers in Drug Development: A Handbook of Practice, Application, and Strategy Cover Image
Pricing & Availability
Available: 0
List Price:$204.00

Email this title to a friend Email this title to a friend
Printer friendly version Printer friendly version

Other formats:
Book Information
Edition: 1st
Publisher: Wiley, John & Sons, Inc.
ISBN: 0-470-16927-3 (0470169273)
ISBN-13: 978-0-470-16927-8 (9780470169278)
New Edition: 1-119-18750-8
Binding: Hardcover
Copyright: 2010
Publish Date: 02/10
Weight: 2.58 Lbs.
Pages: 800
Carton Quantity: 12
Subject Class: PRM (Pharmacology)
Remarks:
A New Edition of this Title is Available
Return Policy: Returns accepted up to 12 months provided no other recalls or return restrictions apply.
Table Of Contents: View
Contributing Authors: View
ProQuest Ebook Central: Also available in ProQuest Ebook Central Available in ProQuest Ebook Central™ View
 
Class Specifications
Discipline: Pharmacology
Subject Definition: Biomarkers, Pharmacological; Drug Design; Drug Discovery
NLM Class: QV 744
LC Class: R853
Abstract: As pharmaceutical companies struggle to improve the success rate and cost-effectiveness of thedrug development process, biomarkers have emerged as a valuable tool. This book synthesizes and reviews the latest efforts to identify, develop, and integrate biomarkers as a key strategy in translational medicine and the drug development process. Filled with case studies, the book demonstrates how biomarkers can improve drug development timelines, lower costs, facilitate better compound selection, reduce late-stage attrition, and open the door to personalized medicine. Each of the thirty-eight chapters was contributed by one or more leading experts, including scientists from biotechnology and pharmaceutical firms, academia, and the U.S. Food and Drug Administration. Their contributions offer pharmaceutical and clinical researchers the most up-to-date understanding of the strategies used for and applications of biomarkers in drug development.

Follow Matthews Book Co. on:
Follow Matthews Book Co. on Twitter

Copyright © 2001-2024 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews Privacy Statement